Spinal cord stimulation  by Claeys, L.
512 Correspondence 
"other ailments" and, therefore, cannot agree that the 
control group contains a large proportion of patients 
in good health simply because they are on a waiting 
list for minor procedures. 
We agree that generic questionnaires such as the 
NHP may underestimate he quality of life and that 
the effect of additional ailments could confound 
attempts at assessing the impact of claudication on 
quality of life (as considered in the 'Discussion' section 
of the paper). We are, however, not aware of a 
validated disease specific questionrkaire for inter- 
mittent claudication. 
H. S. Khaira 
Sutton Coldfield, U.K. 
Spinal Cord Stimulation 
Sir, 
It has been suggested uring the last decades that SCS 
improves limb salvage and reduces tissue loss in 
patients with non-reconstructable critical imb ischae- 
mia. However, the demonstration of a limb saving 
effect requires randomised, controlled prospective 
studies. The study of Jivegard et al. is one of the first 
multicentre studies evaluating the hypothesis that SCS 
improves limb salvage in patients with non-recon- 
structable critical limb ischaemia. ~ 
Patient selection was based on the criteria published 
in the Second European Consensus Document on 
2 Chronic Critical Leg Ischaemia. Analysing the data 
listed in Table 2, 21 (84%) of the 25 patients in the SCS- 
group, and 24 (92%) of the 26 patients in the control 
group had critical imb ischaemia. The clinical stage of 
the remaining four patients in the SCS-group (16%) 
and two patients in the control group (8%), is not clear 
and should be discussed. The analysis of this study 
was by "intention to treat", and every patient rando- 
mised to SCS was analysed, however three patients 
(12%) were never implanted. At 18 months the 
investigators found a 17% difference in limb salvage, 
62% with SCS and 45% without. This result was not 
statistically significant, probably due to the small 
number of patients and the fact that patient selection 
was only based upon macrocirculatory parameters. 
During the last years more than 7000 stimulators have 
been implanted across Europe for "peripheral vas- 
cular disease". On the other hand the 1994 European 
multicentre randomised study sought over 3000 
patients and was stopped due to problems with 
patient enrollment. This shows clearly that patient 
selection and definition of "non-reconstructability" is 
the key problem. However, we need a strict definition 
of the non-reconstructable patient, in order to compare 
and interpret he published ata. 
We know from our clinical experience with SCS that 
many patients with critical limb ischaemia will not 
respond to stimulation therapy. Only the use of very 
strict selection criteria, based upon morphology and 
function of the microcirculation can reduce the num- 
ber of non-responders. The prognostic value of micro- 
circulatory parameters (e.g. TcP02), regarding ulcer 
healing under stimulation has been shown in different 
studies. 3'4 This was also studied in the 120 patients of 
the Dutch multicentre prospective randomised study 
and it seemed that initial TcP02 and the number of 
perfused capillaries were predictors of limb salvage. 5 
It is then also obvious that objective methods for the 
study of the microcirculation should be available at 
those institutions performing stimulation for vascular 
indications. 
In the evaluation of stimulation procedures, ther- 
apeutic success is often equated with pain relief or 
pain reduction. However, therapeutic success is not 
synonymous with pain reduction. 6 Intake of analge- 
sics, functional improvement, quality of life, cost 
effectiveness calculations and adverse vents are also 
important aspects of therapeutic outcome. Therefore, 
the same concepts as in pain research should be 
adopted and assessment of the different parameters 
should be performed by an independent third party. 
The major disadvantages of the visual analogue scale 
is its assumption that pain is a unidimensional 
experience. Therefore, the use of other methods, like 
the McGill Pain Questionnaire is recommended. 7 
The following conclusions can be made: (1) spinal 
cord stimulation provides a significant long-term pain 
relief, and improves ignificantly ulcer healing due to 
effects on the nutritional skin blood flow, (2) effects on 
limb survival are not proven. Further multicentre 
clinical research is needed to evaluate the exact place 
of spinal cord stimulation in the treatment of critical 
limb ischaemia. Better coordination between the dif- 
ferent SCS-centres i mandatory. Studies investigating 
the cost effectiveness of stimulation are also 
necessary. 
L. Claeys 
Vienna, Austria 
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Authors' Reply 
Sir, 
Our prospective randomised study 1 was started in 
1985, i.e. before the first European Consensus Docu- 
ment on critical imb ischaemia (CLI) was published. 2 
Nevertheless, most patients included in our study 
fulfilled the later defined criteria 2 for CLI. The 
remaining patients all had rest pain and/or  ischaemic 
ulcers and/or  partial gangrene although ankle and toe 
pressures were higher than that defined for CLI. 2 The 
numerical difference in limb salvage rates between the 
spinal cord stimulation (SCS) and the control groups 
in our study was non-significant and a limb-saving 
effect by SCS was thus not demonstrated. 
As mentioned by Dr Claeys, demonstration of a 
limb saving effect requires larger numbers obtained in 
prospective randomised controlled studies. To our 
knowledge, no study demonstrating a limb saving 
effect by SCS in "non-reconstructable" CLI patients 
has yet been published. The 1994 European multi- 
center andomised study was designed to study limb 
salvage by SCS versus a control group in a large scale 
study of patients with "non-reconstructable" CLI but 
was stopped during its first year because it was 
concluded that it could not be completed within a 
reasonable time (due mainly to too few active centres 
in relation to the number of patients needed) and with 
adequate data. The latter conclusion was mainly based 
on protocol violations in a few centres where control 
group patients that failed to improve during early 
follow up had been given SCS. For "non-reconstruct- 
able" patients with CLI, there is still a need for a large 
scale prospective randomised study (SCS versus a 
control group) requiring some 25 large vascular 
centres strictly adhering to the study protocol. We 
agree with Dr Claeys that patient selection and the 
definition of "non-reconstructability" aretwo impor- 
tant factors regarding studies of SCS in CLI patients. 
A predictive value of preoperative TcPO2 or capil- 
lary microscopy regarding limb salvage by SCS can be 
evaluated in randomised controlled studies. The 
results of the Dutch multicentre prospective rando- 
mised study are not yet publ isheddWe await publica- 
tion of the Dutch data before we consider introducing 
microcirculatory studies in patients with "non-recon- 
structable" CLI. Finally we agree that further multi- 
centre studies are needed to evaluate, in a prospective 
randomised controlled form, the effects of SCS in 
patients with CLI including cost-effectiveness and 
quality of life aspects which unfortunately were not 
studied in our prospective randomised study. 
L. Jivegfird, L.-E. Augustinsson, J. Holm and 
P. Ortenwall 
G6teborg, Sweden 
B. Risberg 
Malta6, Sweden 
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Blood Pressure after Bilateral Carotid Surgery 
Sir, 
Boyle et al. recently described an interesting case of 
baroreceptor dysfunction soon after bilateral carotid 
body tumour surgery ~and suggested that there had 
been no previous reports of this phenomenon. In fact, 
in a recent report, Robertson et al. described 11 cases of 
baroreceptor failure, four of which were secondary to 
bilateral carotid body tumour surgery. 2 Hypertension 
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